Stanley-Laman Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-14,293
Closed -$229K 239
2022
Q4
$229K Buy
+14,293
New +$233K 0.04% 198
2019
Q4
Sell
-12,906
Closed -$228K 274
2019
Q3
$228K Buy
12,906
+620
+5% +$12.5K 0.06% 249
2019
Q2
$263K Buy
+12,286
New +$257K 0.06% 238

Other funds holding EXEL

Stanley-Laman Group's EXEL Position: Q1 2023 in Review

Stanley-Laman Group sold out of Exelixis (EXEL) in Q1 2023, closing a stake of 14,293 shares — an estimated $229K sold.

Stanley-Laman Group first reported a position in EXEL in Q2 2019 and held it in 3 quarters. The position peaked at $263K in Q2 2019. 363 funds tracked by Wall St. Rank hold EXEL as of Q1 2023.

  • Stanley-Laman Group reported no remaining Exelixis position as of Q1 2023 after selling out during the quarter.
  • Stanley-Laman Group sold 14,293 Exelixis shares in Q1 2023, an estimated $229K.
  • Stanley-Laman Group first reported a position in Exelixis in Q2 2019 and held it in 3 quarters.
  • Stanley-Laman Group's Exelixis position peaked at $263K in Q2 2019.
  • 363 funds tracked by Wall St. Rank held Exelixis as of Q1 2023.

Based on Stanley-Laman Group's 13F filing for Q1 2023, filed 18 Apr 2023.